7-[4-(4-氟苯基)-6-异丙基-2-(N-甲基甲磺酰胺基)-5-嘧啶]-(3R)-叔丁基二甲硅氧基-5-氧代-(6E)-庚酸甲酯结构式
|
常用名 | 7-[4-(4-氟苯基)-6-异丙基-2-(N-甲基甲磺酰胺基)-5-嘧啶]-(3R)-叔丁基二甲硅氧基-5-氧代-(6E)-庚酸甲酯 | 英文名 | 7-[4-fluorophenyl]-6-isopropyl)-2-(N-Methyl-N-MethylSulfonyl amino)pyrimidine-5-yl]-(3R)-3-(terbutyldimethylsilyloxy)-5-oxo-6E-heptane acid,Methyl ester |
---|---|---|---|---|
CAS号 | 147118-38-5 | 分子量 | 607.809 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 679.1±65.0 °C at 760 mmHg | |
分子式 | C29H42FN3O6SSi | 熔点 | N/A | |
MSDS | N/A | 闪点 | 364.5±34.3 °C |
中文名 | 7-[4-(4-氟苯基)-6-异丙基-2-(N-甲基甲磺酰胺基)-5-嘧啶]-(3R)-叔丁基二甲硅氧基-5-氧代-(6E)-庚酸甲酯 |
---|---|
英文名 | 7-[4-fluorophenyl]-6-isopropyl)-2-(N-Methyl-N-MethylSulfonyl amino)pyrimidine-5-yl]-(3R)-3-(terbutyldimethylsilyloxy)-5-oxo-6E-heptane acid,Methyl ester |
中文别名 | 瑞舒伐他汀钙中间体J8 | 7-[4-(4-氟苯基)-6-异丙基-2-(N-甲基甲磺酰胺基)-5-嘧啶]-3R-叔丁基二甲硅氧基-5-氧代-6E-庚酸甲酯 | 瑞舒伐他汀中间体H-1 |
英文别名 | 更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 679.1±65.0 °C at 760 mmHg |
分子式 | C29H42FN3O6SSi |
分子量 | 607.809 |
闪点 | 364.5±34.3 °C |
精确质量 | 607.254761 |
PSA | 124.14000 |
LogP | 5.42 |
蒸汽压 | 0.0±2.1 mmHg at 25°C |
折射率 | 1.528 |
~99% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:ORCHID CHEMICALS and PHARMACEUTICALS LIMITED Patent: WO2008/93205 A2, 2008 ; Location in patent: Page/Page column 7-8 ; |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
~% 7-[4-(4-氟苯基)-6-... 147118-38-5 |
文献:Bioorganic and Medicinal Chemistry, , vol. 5, # 2 p. 437 - 444 |
上游产品 7 | |
---|---|
下游产品 3 | |
6-Heptenoic acid, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-oxo-, methyl ester, (3R,6E)- |
Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(6E)-heptanoate |
methyl (3R,6E)-3-{[tert-butyl(dimethyl)silyl]oxy}-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl]-5-oxohept-6-enoate |
Methyl (3R,6E)-3-{[tert-butyl(dimethyl)silyl]oxy}-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-5-oxohept-6-enoate |
methyl 7-[4-(4-fluorofenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenate |
(3R,6E)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-oxo-6-heptenoic acid methyl ester |
methyl (3R,6E)-3-[[(1,1-dimethylethyl)dimethylsilyl]-oxo]-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidyl]-5-oxo-6-heptenoate |
methyl 7-[4-(4-flourophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenoate |
methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenate |
6-Heptenoic acid,3-[[(1,1-diMethylethyl)diMethylsilyl] oxy]-7-[4-(4-fluorophenyl)-6-(1-Methylethyl)-2-[Methyl (Methylsulfonyl)aMino]-5-pyriMidinyl]-5-oxo-,Methyl ester,(3R,6E) |
methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenoate |
Methyl (3R,6E)-3-{[dimethyl(2-methyl-2-propanyl)silyl]oxy}-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl}-5-oxo-6-heptenoate |